Genetic regulation and targeted reversal of lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
Lloyd D. HarveyiD, Mona AlotaibiiD, Yi‐Yin TaiiD, Ying TangiD, Hee‐Jung J. KimiD, Neil J. KellyiD, Wei SuniD, Chen-Shan Chen WoodcockiD, Sanya Arshad, Miranda K. CulleyiD, Wadih El KhouryiD, Rong XieiD, Yassmin Al AarajiD, Jingsi Zhao, Neha HafeeziD, Rashmi J. Rao, Siyi JiangiD, Vinny NegiiD, Anna KirillovaiD, Dror PerkiD, Annie M.M. WatsoniD, Claudette M. St. CroixiD, Donna Beer StolziD, Ji Young LeeiD, Mary Hongying ChengiD, , Stephen Y. ChaniD
Abstract
Vascular inflammation critically regulates endothelial cell (EC) pathophenotypes, particularly in pulmonary arterial hypertension (PAH). Dysregulation of lysosomal activity and cholesterol metabolism have known inflammatory roles in disease, but their relevance to PAH is unclear. In human pulmonary arterial ECs and in PAH, we found that inflammatory cytokine induction of the nuclear receptor coactivator 7 (NCOA7) both preserved lysosomal acidification and served as a homeostatic brake to constrain EC immunoactivation. Conversely, NCOA7 deficiency promoted lysosomal dysfunction and proinflammatory oxysterol/bile acid generation that, in turn, contributed to EC pathophenotypes. In vivo, mice deficient for Ncoa7 or exposed to the inflammatory bile acid 7-hydroxy-3-oxo-4-cholestenoic acid (7HOCA) displayed worsened PAH. Emphasizing this mechanism in human PAH, an unbiased, metabolome-wide association study (N=2,756) identified a plasma signature of the same NCOA7-dependent oxysterols/bile acids associated with PAH mortality (P View larger version (39K): org.highwire.dtl.DTLVardef@896f6forg.highwire.dtl.DTLVardef@f31c2eorg.highwire.dtl.DTLVardef@bf46dcorg.highwire.dtl.DTLVardef@1c55686_HPS_FORMAT_FIGEXP M_FIG Graphical abstract. C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 56
- FWCI
- 31.80
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension
B. Piper, S. Bogamuwa, … L. Farkas·Journal of Clinical InvestigationPeer-reviewed·Feb 1, 2024
- Disruption of DLL4/NOTCH1 Causes Dysregulated PPARγ/AKT Signaling in Pulmonary Arterial Hypertension
Keytam S. Awad, Shuibang Wang, … Robert L. Danner·bioRxiv·Jan 31, 2024
- Endothelial PHD2 Deficiency Induces Nitrative Stress via Suppression of Caveolin-1 in Pulmonary Arterial Hypertension
- LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension
J. Steppan, H. Wang, … L. Santhanam·bioRxiv·Oct 24, 2023
- Ferroptosis Integrates Mitochondrial Derangements and Pathological Inflammation to Promote Pulmonary Hypertension
F. Kazmirczak, N. T. Vogel, … K. Prins·bioRxiv·Jan 19, 2023
- The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension
Navneet Singh, Jordan Lawson, … Corey E. Ventetuolo·bioRxiv·Oct 3, 2025